Followers | 2457 |
Posts | 79992 |
Boards Moderated | 0 |
Alias Born | 06/15/2009 |
Wednesday, January 15, 2020 9:24:17 AM
Recent VRNA News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 02:47:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/07/2024 11:56:12 PM
- Verona Pharma to Present at Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/05/2024 07:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/04/2024 01:47:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 11:06:03 AM
- Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/04/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 11:17:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2024 11:13:20 PM
- Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 10/21/2024 06:00:00 AM
- Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024 • GlobeNewswire Inc. • 09/30/2024 06:00:00 AM
- Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024 • GlobeNewswire Inc. • 09/05/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 11:12:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:51:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:44:28 PM
- Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:28:45 AM
- Verona Pharma to Present at 44th Annual Canaccord Growth Conference • GlobeNewswire Inc. • 07/30/2024 06:00:00 AM
- Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 07/25/2024 06:00:00 AM
- Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine) • GlobeNewswire Inc. • 06/26/2024 08:57:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 01:09:53 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 12:53:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:22:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:18:24 AM
- Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:15:00 AM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM